Tagalogon, Morito .

HRN: 21-81-84  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CEFUROXIME 1.5GM (VIAL)
08/17/2022
08/23/2022
IVT
1.5gms
Q8
Uti, Cvd Bleed Left Mca
Waiting Final Action 
08/18/2022
CEFTRIAXONE 1G (VIAL)
08/18/2022
08/25/2022
IV
2g
Q24H
Cap MR, UTI
Waiting Final Action 
08/20/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/20/2022
08/27/2022
IV
4.5grams
Q6hrs
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: